Can polycythemia vera cause itching?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Polycythemia Vera Cause Itching?

Yes, polycythemia vera definitively causes itching (pruritus), which is a characteristic and common symptom occurring in approximately 48% of patients either at diagnosis or during the disease course. 1

Clinical Characteristics of PV-Associated Pruritus

Aquagenic pruritus is the hallmark presentation—intense itching triggered specifically by contact with water at any temperature, without visible skin lesions. 1 This water-induced itching is so characteristic of PV that it should prompt hematological investigation. 1

Key features include:

  • Location: Primarily affects the trunk and proximal extremities 2
  • Quality: Most patients (71.8%) describe itching, while others report tickling, stinging, or burning sensations 2
  • Severity: Approximately 14.6% of patients classify the pruritus as "unbearable" 2
  • Timing: In 64.8% of cases, aquagenic pruritus occurs an average of 2.9 years before the diagnosis of PV is made 2
  • Impact: Significantly reduces quality of life, causing sleep deprivation and interference with social and physical activities 1

Pathophysiology

The exact mechanism remains incompletely understood, but platelets and their contents (including prostaglandins and serotonin) are implicated in the pathogenesis. 1 Iron deficiency may also play a contributory role, as there is a significant correlation between active pruritus and low mean corpuscular volume. 1

Diagnostic Approach

When evaluating a patient with generalized pruritus:

  • Check complete blood count looking for elevated hemoglobin/hematocrit, microcytosis (suggesting iron deficiency from phlebotomy), elevated white cells or platelets, and low ESR 1
  • Test for JAK2 V617F mutation if PV is suspected—this mutation is present in up to 97% of PV cases 1
  • Consider PV specifically when aquagenic pruritus is present, even if blood counts appear normal initially 1

Treatment Algorithm

First-Line Management

Low-dose aspirin (81-300 mg daily) should be the initial treatment, as it produces prompt relief (within hours) in most patients by inhibiting platelet release of pruritogenic substances. 1

Second-Line Options

If aspirin fails or provides inadequate relief:

  • Selective serotonin reuptake inhibitors (SSRIs) such as paroxetine show response rates higher than 80% 1, 3
  • Antihistamines can be tried, though responses are unpredictable and variable 1

Refractory Cases

For intractable pruritus, interferon-α is the recommended treatment, reducing pruritus in up to 81% of affected patients. 1, 3 This has the added benefit of providing cytoreductive therapy for the underlying PV. 1, 4

Alternative therapies with limited evidence include:

  • Phototherapy (PUVA or UVB) 1, 5
  • Sodium bicarbonate baths (though not consistently effective) 1
  • Ruxolitinib (JAK1/JAK2 inhibitor) has shown very effective rapid reductions in pruritus scores in recent trials 1

Critical Clinical Pitfalls

The pruritus can persist despite normalization of blood counts with phlebotomy or cytoreductive therapy, so don't assume hematologic control will resolve the itching. 1 Only 5.6% of patients have complete resolution with PV-directed therapy alone. 2

Avoid indiscriminate iron replacement—while iron deficiency may contribute to pruritus, iron supplementation is not consistently effective and is discouraged without clear indication. 1

Don't dismiss aquagenic pruritus as trivial—it frequently precedes the diagnosis of PV by years and represents a significant quality-of-life issue that warrants aggressive management. 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Polycythemia Vera Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.